Dieli-Conwright Laboratory News

April 2024

  • PhD students Cami Christopher and Amber Normann presented posters at the American Association for Cancer Research (AACR) annual meeting where they presented on results of our pilot study that shows the effects of 16-week circuit, interval-based aerobic and resistance clinical exercise intervention on improvements in vascular function and reductions in cardiovascular disease risk among breast, prostate and colorectal cancer survivors.
  • The Dieli-Conwright lab is excited to introduce our new postdoctoral fellow, Anderson Vulczak! Anderson completed a Ph.D. in Sciences with a concentration in Public Health from the University of São Paulo at Ribeirao Preto College of Nursing - PAHO / WHO Collaborating Center for Nursing Research Development, in partnership with the School of Pharmaceutical Sciences, Ribeirao Preto - Sao Paulo – Brazil. To learn more about Anderson, please click here.​
  • We are excited to announce that Rebekah Wilson has been promoted to Senior Research Scientist in the Division of Population Science at DFCI.
  • We are excited to announce that Mary Norris has been promoted to CTO Senior Research Project Manager in the Division of Population Science at DFCI.

March 2024

  • PhD student Cami Christopher presented an oral presentation at the New England Science Symposium on the impact of an exercise intervention on vascular function among cancer survivors. She was awarded the Dana-Farber/Harvard Cancer Center Award for Cancer Research and third prize for the Ruth and William Silen Award for oral presentation.
  • The Dieli-Conwright lab is excited to introduce our new postdoctoral fellow, Liz Cox! Liz received her PhD in experimental psychology from the University of Toronto. To learn more about Liz, please click here.​
  • The Dieli-Conwright lab is excited to introduce our new clinical research coordinator, Jocelyn Greer! Jocelyn graduated from Mount Holyoke College, where they created a specialized major and received a BA in Exercise Psychology. To learn more about Jocelyn, please click here.​

February 2024

  • The Dieli-Conwright lab is excited to introduce our new postdoctoral fellow, Salvatore Ficarra! Salvatore obtained a PhD in Health Promotion and Cognitive Sciences at the University of Palermo in 2023. To learn more about Salvatore, please click here.​
  • We are excited to announce that Danny Nguyen has been promoted to Clinical Research Coordinator II in the Division of Population Science at DFCI.

January 2024

  • PhD student Cami Christopher was selected to present an oral presentation at the Dana-Farber/Harvard Cancer Center Celebration of Early Career Investigators Symposium. She presented on the effects of a circuit, interval-based aerobic and resistance exercise program to improve endothelial function and vascular wall thickness among cancer survivors.
  • The Dieli-Conwright lab is excited to introduce our new project manager, Jordan Lane! Jordan earned a BSc in Exercise Physiology from The College at Brockport and a MSc in Sports Medicine with a focus on research from the University of Pittsburgh. To learn more about Jordan, please click here.​
December 2023
  • We are pleased to announce a new publication in Nutrients. The article reviews the evidence on exercise and nutritional interventions during the pre-operative prehabilitation period for hepato-pancreato-biliary (HPB) cancer populations. Click here to read the full article.
  • The Dieli-Conwright lab celebrated postdoctoral fellow, Paola Gonzalo-Encabo, as she accepted an Instructor position at the University of Alcala.

October 2023

  • We are pleased to announce a new invited publication in Journal of the American College of Cardiology, CardioOncology. This state of the art review discusses cancer treatment–induced cardiotoxicities, reviews the existing evidence supporting the role of exercise in preventing and managing these sequelae in at-risk and affected individuals living after cancer diagnoses, and proposes considerations for implementing exercise-based services in cardio-oncology practice. Click here to read the full article.

September 2023

  • The Dieli-Conwright lab is excited to introduce our new PhD student, Simone Cuomo! Simone received a BS in Sports and Exercise Science in 2015 and an MS in Sport Science for Prevention and Rehabilitation in 2019 from the University of Turin. To learn more about Simone, please click here.​

August 2023

  • Undergraduate student Kelly Lochlin participated in the SPARC/CURE summer program, with her mentor, PhD student Cami Christopher. Kelly's summer project examined how a high-intensity interval training program impacted mood among breast cancer patients receiving chemotherapy.

June 2023

  • Rebekah Wilson, Dong-Woo Kang, and Paola Gonzalo-Encabo presented a tutorial lecture at the 2023 ACSM meeting in Denver. This lecture discussed how to maintain the rigor and effectiveness of in-person exercise in the virtual supervised environment. 



​
  • Rebekah Wilson presented the results of a cross sectional study at the 2023 ACSM meeting in Denver. This analysis aimed to epidemiologically characterize the nutritional status of young adult survivors of pediatric central nervous system tumors using body mass index to assess risk factors for obesity. 
  • The Dieli-Conwright lab is excited to introduce our new clinical research coordinator, Jack Gardiner! Jack recently graduated from Boston University Sargent College with his BS in Human Physiology. He also obtained his MPH in Epidemiology & Biostatistics from Boston University School of Public Health. To learn more about Jack, please click here.​
May 2023
  • We are pleased to announce a new publication in Nutrients. The article presents findings on a cross-sectional study analyzing obesity risk of pediatric CNS tumor survivors. Click here to read the full article.
  • The Dieli-Conwright lab is excited to introduce our new clinical research coordinator, Michelle Perez! Michelle obtained a Bachelor of Arts in Biological Sciences with a minor in Chemistry from Mount Holyoke College. She also gained a Master’s in Biomedical Sciences at the Duke University School of Medicine. To learn more about Michelle, please click here.​
  • PhD student Cami Christopher received the Simonian Award for Academic Excellence from the Department of Nutrition at the Harvard T.H. Chan School of Public Health.

March 2023

  • PhD student Cami Christopher attended the American Society for Preventive Oncology (ASPO) annual meeting and presented a poster sharing the findings of an exercise intervention to improve metabolic syndrome and sarcopenic obesity among Black and Hispanic cancer survivors. Cami also presented this poster at the 2023 New England Science Symposium
February 2023
  • We are excited to announce that Dong-Woo Kang has been promoted from Postdoctoral Fellow to Instructor in the Division of Population Science at DFCI. 
January 2023
  • We are pleased to announce a new publication in Cancer Epidemiology, Biomarkers & Prevention. The article discusses the impact of moderate-vigorous physical activity trajectories on colon cancer risk over the adult life course. Click here to read the full article.
December 2022
  • Rebekah Wilson presented the design of the RESTART Trial at the 2022 American Society of Hematology (ASH) Annual Meeting. This trial will investigate the impact of a 12 week virtually supervised aerobic and resistance-based exercise intervention on glycemic control, body composition, physical function, and patient reported outcomes in patients diagnosed with graft-versus-host-disease receiving corticosteroids. ​
November 2022
  • Amber Normann presented the design of the PROTECT Trial at the 2022 American Institute of Cancer Research (AICR) Annual Meeting. This trial will investigate the impact of prehabilitative exercise on lower limb muscle strength in patients with multiple myeloma scheduled to receive autologous stem cell transplant. 
  • We are pleased to announce a new publication in the Scandinavian Journal of Medicine & Science in Sports. The article explores how high intensity training can improve metabolic syndrome in women with breast cancer receiving anthracyclines. Click here to read the full article.
October 2022
  • Dong-Woo Kang presented the changes in immune parameters after 12-week high-intensity interval training (HIIT) in men with prostate cancer undergoing active surveillance, at the International Society of Exercise Immunology in Tucson, AZ. He found that a 12-week HIIT increased NK cell cytotoxicity and induced a meaningful trend of increase in NK cell proportion in men with low-grade prostate cancer undergoing active surveillance.​
  • We are thrilled to announce that Dong-Woo Kang received the Young Investigator Award from the Prostate Cancer Foundation. With the mentorships from Drs. Christina Dieli-Conwright, Alicia Morgans, and Timothy Rebbeck, he secured 3-year funding for an RCT to investigate the effects of exercise on the biochemical progression of prostate cancer in Black men undergoing active surveillance.​

September 2022

  • Cami Christopher presented during the Dana-Farber/Harvard Cancer Center (DF/HCC) Brief Updates on Obesity, Metabolism, and Cancer. She presented on a pilot study showcasing how a circuit, interval-based exercise program improved metabolic syndrome and sarcopenic obesity in overweight and obese Black and Hispanic cancer survivors. Christina Dieli-Conwright also presented as a panelist. 
  • The Dieli-Conwright Lab had the pleasure of attending the Making Strides of Boston Walk sponsored by the American Cancer Society. The lab met and greeted survivors and thrivers to share the power of exercise and our ongoing studies. 
  • We are pleased to announce a new publication in BMC. The article highlights the results from a randomized controlled trial studying the effects of supervised high-intensity interval training on motivational outcomes in men with prostate cancer undergoing active surveillance. Click here to read the full article.
  • Christina M Dieli-Conwright and Paola Gonzalo Encabo attended the European Congress of Sport Science Congress in Sevilla, Spain. They were invited to present a symposium entitled “Exercise as medicine in obesity-related breast cancer prevention and survivorship: From muscle to adipose tissue” Christina presented past and ongoing trials regarding the impact of metabolic dysregulation and sarcopenia on cancer-related outcomes and the utilization of exercise to target said health measures in breast cancer survivors. Paola presented past and ongoing studies conducted at the Dieli-Lab regarding the effects of exercise on health outcomes during breast cancer treatments. Furthermore, Paola presented an Oral presentation regarding the effects of HIIT on metabolic syndrome in breast cancer patients receiving anthracycline chemotherapy.
  • Dr. Huiman Yan presented during the AACR Conference: Cancer Health Disparities. She presented our first-of-its-kind exercise trial for Black and Hispanic cancer patients receiving chemotherapy, the THRIVE Trial. 
  • The Dieli-Conwright lab is delighted to introduce our new undergraduate student, Maddie Beckwith! Maddie is a senior pursuing a degree in Exercise Science at Simmons University. To learn more about Gillian​, please click here.​
  • The Dieli-Conwright lab is delighted to introduce our new undergraduate student, Gillian Conley! Gillian is a senior pursuing a degree in Exercise Science at Simmons University. To learn more about Gillian​, please click here.​
  • The Dieli-Conwright lab is excited to introduce our new undergraduate student, Sydney Iannantuono! Sydney is a senior pursuing a degree in Exercise Science at Simmons University. To learn more about Sydney, please click here.​
  • The Dieli-Conwright lab is thrilled to introduce our new undergraduate student, Darryl Tjogas! Darryl is a senior pursuing a degree in Human Physiology at Boston University. To learn more about Darryl, please click here.​
  • The Dieli-Conwright lab is pleased to introduce our new MPH student, Jack Gardiner. Jack is currently pursuing a MPH in Epidemiology and Biostatistics at Boston University School of Public Health. To learn more about Jack, please click here.​

August 2022

  • We are thrilled to announce a new publication in Critical Reviews in Oncology/Hematology. This review summarizes clinical investigations on tumor markers in exercise oncology research. Click here to read the full article.

July 2022

  • We are excited to announce a new publication in Current Oncology Reports. This systematic review explores interventions to reduce sedentary behavior in cancer patients and survivors. Click here to read the full article.
  • The Dieli-Conwright lab is pleased to introduce our new MPH student, Megha Sureka! Megha is currently pursuing a MPH in Epidemiology and Biostatistics at Boston University School of Public Health. To learn more about Megha, please click here.​
June 2022
  • We are excited to announce a new publication in Frontiers. This article details the rationale, design, and methods for the AIM Trial: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors. Click here to read the full article.
  • Dr. Dong-Woo Kang presented the benefits of exercise on metabolic regulation in cancer survivors who are sedentary / obese at the Multinational Association of Supportive Care in Cancer (MASCC22) conference.
  • Cami Christopher attended the American Society of Clinical Oncology (ASCO) National Conference where she presented on a pilot study showcasing how a circuit, interval-based exercise program improved adiponectin levels and insulin resistance in Black and Hispanic cancer survivors. Cami also presented on the design for the AIM trial, an ongoing trial in the Dieli-Conwright lab comparing circuit-based exercise to traditional aerobic and resistance exercise on systemic and adipose tissue inflammation in obese breast cancer survivors. Click here to read more. 
  • Rebekah Wilson and Paola Gonzalo Encabo attended the Congress of the American College of Sports Medicine (ACSM) in San Diego, where they presented two posters with the results of our pilot study that shows the effects of 16-week time-efficient circuit, interval-based aerobic and resistance clinical exercise intervention on increases in physical function, VO2max and strength in survivors of breast, prostate and colorectal cancers.
  • We are delighted to announce a new publication in Frontiers. The article highlights the protocol of the ROSA Trial: Reducing Metabolic Dysregulation in Obese Latina and/or Hispanic Breast Cancer Survivors Using Physical Activity. Click here to read the full article.
  • We are pleased to announce a new publication in MDPI. This systematic review highlights the effects of exercise and nutritional interventions on body composition in patients with advanced or metastatic cancer. Click here to read the full article.
  • We are thrilled to announce a new publication in Critical Reviews in Oncology / Hematology. The article explores virtually supervised exercise interventions as a sustainable alternative oncology during and beyond the COVID-19 pandemic. Click here to read the full article.

May 2022

  • The Dieli-Conwright lab is pleased to introduce our new PhD student, Salvatore Ficarra! Salvatore Ficarra received his BS in Sports Science in 2018 and his MS in Adapted Physical Activity in 2020 from the University of Palermo in Italy.  To learn more about Salvatore, please click here.​
  • The Dieli-Conwright lab is thrilled to announce Rebekah Wilson's promotion to the role of Research Scientist II.
  • On May 9th, our undergraduate research fellow Joseph (Joey) Yap presented his senior thesis for distinction: "Physical Function and Depression in Breast, Colorectal, and Prostate Cancer Survivors Following a 16-Week Circuit-Based Aerobic and Resistance Exercise Intervention". This thesis found clinically significant increases in SPPB-derived physical function and CES-D-derived depression scores following the intervention, and Joey hopes that the results can go towards improving patient lives and wellbeing following chemotherapy. To read his thesis, click here. 
​
April 2022
  • Dr. Dong-Woo Kang presented the design of our ACTIVATE Trial at the 2022 American Association for Cancer Research (AACR). This trial investigates the impacts of circuit interval-based exercise on systemic inflammation in obese, sedentary cancer survivors. 
​March 2022
  • Amber Normann presented the design for the ACTIVATE Trial at the 2022 American Society of Preventative Oncology (ASPO) conference. This trial investigates sleep quality associated with reduced insulin resistance in cancer survivors undertaking circuit, interval-based exercise. Amber was selected as a top scoring abstract and received a travel reward. Amber is the first trainee from the Dieli-Conwright lab to deliver an in-person presentation at a conference. 

February 2022

  • We are excited to announce a new publication in BMC Women's Health. The article focuses on the results of the Women's Health Initiative, which includes cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality. Click here to read the full article.
  • We are delighted to announce a new publication in the Journal of Urology.  The article highlights the effects of exercise on anxiety, fear of cancer progression and quality of life in prostate cancer patients on active surveillance. Click here to read the full article.

January 2022

  • We are thrilled to announce a new publication in Frontiers. The article focuses on exercise as a potential therapeutic modality in the management of anthracycline-induced cardiotoxicity. Click here to read the full article.
  • Dr. Dong-Woo Kang won the most innovative idea award after presenting at 9th Annual Dana-Farber/Harvard Cancer Center Celebration of Early Investigators in Cancer Research​. His poster showcased a randomized trial that focused on the impacts of aerobic exercise on cardiorespiratory fitness and biochemical progression in men with prostate cancer on active surveillance. ​
Picture
Click to Enlarge
  • Cami Christopher also presented at the Annual Dana-Farber/Harvard Cancer Center Celebration of Early Investigators in Cancer Research​. Her poster features a pilot study that emphasized the effects of circuit, interval-based exercise on insulin resistance and adiponectin in minority cancer survivors.
Picture
Click to Enlarge
November 2021​​
  • We are excited to announce a new publication in Supportive Care in Cancer. The article focuses on the effect of high-intensity interval training on patient-reported outcomes and physical function in women with breast cancer receiving anthracycline-based chemotherapy. Click here to read the full article.
  • Dr. Dong-Woo Kang presented the design of our CLARITY Trial at the 2021 American Institute for Cancer Research (AICR) conference. This trial investigates the impacts of high-intensity interval training on cognitive function in women with breast cancer undergoing chemotherapy.
Picture
Click to Enlarge
  • We are proud to announce that Dr. Dieli-Conwright and Dr. Kang, in collaboration with Dr. Tim Rebbeck and Dr. Paul Nguyen, received funding from the Pfizer-Prostate Cancer Canada Health Equity Challenge Award for our POWER Trial to study the effects of exercise on cardiovascular health among Black prostate cancer patients undergoing androgen deprivation therapy.
  • We are thrilled to announce that Dr. Dieli-Conwright, in collaboration with Dr. Jeff Meyerhardt, Dr. Brian Wolpin, and Dr. Michael Rosenthal, received funding from the Friends of Dana-Farber Funding for our REBUILD Trial to study the effects of resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing chemotherapy.
October 2021
  • We are pleased to announce a new publication in Sleep. The article reports that aerobic and resistance exercise improved patient-reported sleep quality and is associated with cardiometabolic biomarkers in Hispanic and non-Hispanic breast cancer survivors who are overweight or obese. Click here to read the full article.
  • We are excited to announce that Dr. Dieli-Conwright, in collaboration with Dr. Huimin Yan, received NIH U54 funding for our THRIVE Trial to test home-based exercise strategies to improve exercise participation and cardiovascular health in underserved minority patients with cancer undergoing chemotherapy. ​
September 2021
  • We are excited to announce a new publication by Alexandra Yunker in JAMA Network Open. The article reports the obesity and sex-related associations with differential effects of sucralose vs sucrose on appetite and reward processing from a randomized crossover trial. Click here to read the full article .
  • We are pleased to share our recent publication in Nutrients. The article focuses on the potential synergism of fasting and exercise combined interventions. Click here to read the full article.
  • The Dieli-Conwright lab is excited to introduce our new clinical research coordinator, Danny Nguyen! Danny is a recent graduate from Tufts University with a BA in Spanish Language and Culture. To learn more about Danny, please click here.​
  • The Dieli-Conwright lab is pleased to introduce our new PhD student, Amber Normann! Amber Normann received a BS in Molecular & Cell Biology from the University of California, Merced and a MS in Kinesiology, option in Exercise Science from California State University, Long Beach. To learn more about Amber, please click here.​
  • The Dieli-Conwright lab is excited to introduce our new masters student, ​Alexandra Yunker! Alex received her BA in Anthropology from the University of California Los Angeles (UCLA) and is currently an MPH in Nutrition Candidate at the Harvard T.H. Chan School of Public Health. To learn more about Alex, please click here.​
August 2021
  • We are thrilled to announce a new publication by Dr. Dong-Woo Kang in JAMA Oncology. The article reports the effects of high-intensity interval aerobic training on cardiorespiratory fitness and biochemical progression of disease in prostate cancer undergoing active surveillance. Click here to read the full article page.
  • We are proud to announce that Dr. Christina Dieli-Conwright is an ambassador for the American Cancer Society (ACS) ResearcHERS: Women Fighting Cancer. The ResearcHERS campaign raises money to support women-led cancer research across the nation.
    ​​To Donate to Dr. Dieli-Conwright’s Lab, click here.
  • We are excited to announce a new publication in Scientific Reports. The article focuses on the effects of aerobic and resistance exercise on the mitochondrial peptide referred to as MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors. Read the full article here. ​
  • The Dieli-Conwright lab is thrilled to introduce our new postdoctoral fellow, Paola Gonzalo-Encabo! Paola received a BS in Sport Science, a master’s degree in Physical Education and a postgraduate course in Personal Training, specializing in Exercise Science and Health from the University of Alcala in Spain. To learn more about Paola, please click here.​
July 2021
  • ​Rebekah presented her work examining a pre-radical prostatectomy weight loss program for prostate cancer patients at the MD Anderson Translating Energy Balance from Bench to Communities: Application of Parallel Animal-Human Studies  conference earlier in July.​​​
  • This month she also published an original study in Cancers highlighting the efficacy of home-based exercise in preserving previously gained benefits from a supervised exercise intervention for prostate cancer patients on androgen deprivation therapy. Read the full article here. ​
June 2021
  • Post-Doctoral Fellow, Dong-Woo Kang, presented his work on the effects of high-intensity interval training in prostate cancer patients undergoing surveillance at the annual ACSM and ASCO meetings.​
Picture
ASCO - Click to Enlarge
Picture
ACSM - Click to Enlarge
  • ​This month, Dr. Dong-Woo Kang's PhD convocation story was featured. ​Read the full article here.
May 2021
  • The Dieli-Conwright lab recently published within the ASCO Educational Book on nutrition and physical activity to prevent breast cancer and control/reduce racial/ethnic cancer health disparities along with our collaborators from Northwell Health and Rutgers University.
  • We are proud to share a new publication in the Journal of Clinical Exercise Physiology. The expert commentary focuses on the unique barriers Sexual and Gender Minorities face across the healthcare spectrum, including engagement in exercise clinical trials. The piece highlights the need for energy balance research in this underrepresented population.
  • We are excited to share that our Post-Doctoral Fellow, Rebekah Wilson, presented her work examining an exercise and nutrition-based weight loss intervention for prostate cancer patients on androgen deprivation therapy at the Exercise Sport Science Australia (ESSA) conference earlier in May, where she was nominated for the Young Investigator Award for Exercise Science and Health. 

    This month she also published a review in Nutrients, discussing the importance of exercise and nutrition in mitigating or reversing androgen deprivation therapy-induced changes in body composition in prostate cancer patients.
April 2021
  • The Dieli-Conwright lab is excited to introduce our newest post-doctoral fellow, Dr. Rebekah Wilson. Dr. Wilson joins us after completing her PhD from Edith Cowan University in Australia. To learn more about Rebekah and her research interests, click here.​
March 2021
  • The Dieli-Conwright Lab presented a poster on “Circuit, interval-based aerobic and resistance exercise improves metabolic syndrome in Black and Hispanic cancer survivors” at the American Society of Preventive Oncology (ASPO) annual conference. Co-authors included Mary Norris, Jackie Dawson (lab alumna) and Christina Dieli-Conwright. ​
Picture
Click to enlarge
February 2021
  • We are pleased to share our recent publication in the Journal of Cancer Survivorship: Research and Practice. The article focuses on the secondary analysis of Hispanic ethnicity as a moderator of the effects of a 16-week aerobic and resistance exercise intervention on physical fitness and quality of life in breast cancer survivors.
  • The Dieli-Conwright lab is thrilled to introduce two new members to our staff. Boston University MPH student, Cami Christopher and Oxford University medical student, Oscar Barnes. To learn more about Cami and Oscar and their research interests, click here .
Picture
Cami Christopher
Picture
Oscar Barnes
  • We are delighted to share that our post-doctoral fellow, Dong-Woo Kang, published in Supportive Care in Cancer. The manuscript focuses on exploring physical activity levels with regard to health inequality factors in Korean cancer survivors.
January 2021
  • The Dieli-Conwright lab is happy to welcome its first post-doctoral fellow, Dr. Dong-Woo (Derek) Kang. Dr. Kang has joined us from the University of Alberta, Canada where he recently earned his doctoral degree in Exercise Oncology. To learn more about Derek and his research interests click here.
November 2020
  • We are ecstatic to announce the Dana-Farber Cancer Institute Susan F. Smith Center for Women’s Cancers Breast & Gynecologic Cancer Innovation Award was granted to Dr. Dieli-Conwright and Dr. Alexi Wright to fund the study of exercise as a preventative agent to combat immobility in ovarian and endometrial cancer patients receiving chemotherapy.
  • We are happy to share a new article on the effects of aerobic and resistance exercise on Reynolds risk score in overweight or obese breast cancer survivors, published in Cardio-Oncology. The article discusses the benefits of exercise on Reynolds risk score, an assessment of cardiovascular disease risk.
September 2020
  • We are excited to share a new manuscript on the feasibility of quantifying change in immune white cells in abdominal adipose tissue during a short course of therapy, published in PLoS One.
August 2020
  • We are delighted to report a new publication led by our colleague, Britni Belcher, PhD, MPH, from the University of Southern California, in the Journal of Psychosomatic Research. The article investigates within-day associations between glucose and subsequent affective and physical feeling states as they occur among healthy adolescents.
June 2020
  • We are pleased to share Dr. Dieli-Conwright and Dr. Jennifer Ligibel received funding from the Dana-Farber Cancer Institute Saverin Breast Cancer Research Fund to study the impact of combined intermittent fasting and exercise on metabolic markers in breast cancer patients with advanced cancer
  • We are excited to share a new review on exercise oncology in minority cancer survivors released in the Journal of Clinical Exercise Physiology. This review discusses the research that has been done within the minority population as well as identifies gaps in the literature and offers future directions for research.
  • We are excited to share our new review on prehabilitative exercise in Current Oncology Reports. This review discusses the effects of prehabilitative exercise on physical, psychosocial, and biological outcomes in patients with cancer.
  • Dr. Dieli-Conwright presented on "Optimizing Cardiometabolic Health with Exercise in Adolescent and Young Adult Cancer Survivors" at the Center for Adolescent and Young Adults Monthly Forum at the Dana-Farber.
May 2020
  • The American College of Sports Medicine (ACSM) Annual Conference went virtual this year, and the Dieli-Conwright Lab attended with virtual abstracts on the benefits of high intensity interval training on patient-reported outcomes in patients receiving chemotherapy, and the association of inflammation and skeletal muscle mass in breast cancer survivors.
April 2020
March 2020
February 2020
  • Dr. Dieli-Conwright joined Drs. Kristen Campbell, Paul LaStayo, Chris Barnes at the APTA Combined Sections Meeting to present "Weight Bench to Bedside: The importance of Muscular Health and Physical Function in Oncology Rehabilitation."  
Picture
  • Mary Norris joined the Dieli-Conwright Laboratory as Lab Manager, at the Dana-Farber Cancer Institute to begin a new chapter of research in exercise oncology. She previously managed our laboratory at the USC in Los Angeles CA. 
Picture
January 2020
  • Dr. Dieli-Conwright joined the faculty of the Dana-Farber Cancer Institute in the Division of Population Sciences, Department of Medical Oncology and Harvard Medical School. 
    ​
    ​    Prior to joining the Dana-Farber Cancer Institute, Dr. Dieli-Conwright was the
    Director of the Integrative Center for Oncology Research in Exercise and Assistant Professor of Biokinesiology and Medicine at the University of Southern California.